{"result": "(\"entity\"<|>ESTRÉS METABÓLICO<|>EVENT<|>Estrés metabólico refers to the increased nutritional needs and metabolic demands placed on cancer patients due to their condition and treatment, which can lead to malnutrition.)\n##\n(\"entity\"<|>CICATRIZACIÓN DE TEJIDOS<|>EVENT<|>Cicatrización de tejidos is the process of healing that requires additional nutritional support, particularly in cancer patients undergoing surgery.)\n##\n(\"entity\"<|>EFECTOS SECUNDARIOS<|>EVENT<|>Efectos secundarios are the adverse reactions experienced by cancer patients due to treatments like quimioterapia and radioterapia, impacting their nutritional intake.)\n##\n(\"entity\"<|>CALIDAD DE VIDA<|>EVENT<|>Calidad de vida refers to the overall well-being of cancer patients, which can be significantly affected by malnutrition and treatment side effects.)\n##\n(\"entity\"<|>MUCOSITIS<|>EVENT<|>Mucositis is a common side effect of cancer treatments that causes inflammation and ulceration in the digestive tract, affecting the ability to eat.)\n##\n(\"entity\"<|>ASTENIA<|>EVENT<|>Astenia is a condition of physical weakness and fatigue that can result from malnutrition and cancer treatments, further impacting the patient's quality of life.)\n##\n(\"relationship\"<|>PACIENTE NEOPLÁSICO<|>ESTRÉS METABÓLICO<|>Estrés metabólico is a significant concern for paciente neoplásico, as their nutritional needs increase due to their condition and treatment.<|>7)\n##\n(\"relationship\"<|>PACIENTE NEOPLÁSICO<|>CICATRIZACIÓN DE TEJIDOS<|>Cicatrización de tejidos is a process that requires adequate nutrition, which is a concern for paciente neoplásico undergoing surgery.<|>6)\n##\n(\"relationship\"<|>PACIENTE NEOPLÁSICO<|>EFECTOS SECUNDARIOS<|>Efectos secundarios from treatments like quimioterapia and radioterapia can severely impact the nutritional status of paciente neoplásico.<|>9)\n##\n(\"relationship\"<|>PACIENTE NEOPLÁSICO<|>CALIDAD DE VIDA<|>Calidad de vida is directly affected by malnutrición and the overall health of paciente neoplásico during treatment.<|>8)\n##\n(\"relationship\"<|>PACIENTE NEOPLÁSICO<|>MUCOSITIS<|>Mucositis is a side effect that can hinder the ability of paciente neoplásico to eat, leading to malnutrition.<|>9)\n##\n(\"relationship\"<|>PACIENTE NEOPLÁSICO<|>ASTENIA<|>Astenia is a common issue for paciente neoplásico, often resulting from malnutrition and treatment side effects.<|>8)\n##\n(\"relationship\"<|>MALNUTRICIÓN<|>ASTENIA<|>Malnutrición can lead to astenia, as the lack of proper nutrition contributes to physical weakness and fatigue in cancer patients.<|>9)\n##\n(\"relationship\"<|>MALNUTRICIÓN<|>MUCOSITIS<|>Mucositis can exacerbate malnutrición by making it difficult for patients to consume adequate nutrition.<|>9)\n##\n(\"relationship\"<|>CALIDAD DE VIDA<|>MALNUTRICIÓN<|>Malnutrición negatively impacts the calidad de vida of cancer patients, leading to a decline in their overall well-being.<|>10)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ugía, el período de ayuno postoperatorio, las complicaciones y las secuelas a largo plazo. La cirugía dificulta la alimentación durante el período postoperatorio que, junto al incremento de las necesidades nutricionales por el estrés metabólico que produce y al aumento de las demandas que conlleva la cicatrización de los tejidos, favorecen la desnutrición en este tipo de pacientes, que en muchas ocasiones ya se encuentra previamente deteriorado. El grado de estrés depende del grado de agresión que, a su vez, en la cirugía del cáncer\n---\n638      BLOQUE: NUTRICIÓN EN ONCOLOGÍA\n\nestá en función de la intención curativa o paliativa del tratamiento. La cirugía de cabeza y cuello, esófago, estómago y páncreas son las que se consideran de más alto riesgo para desencadenar desnutrición.\n\nQuimioterapia. Es un tratamiento agresivo cuyos efectos secundarios dependerán de múltiples factores, como fármacos utilizados, dosis y esquema empleados (mono o poliquimioterapia), duración del tratamiento, respuesta individual, terapias concomitantes y estado general del paciente. Las náuseas y vómitos son los efectos que con más frecuencia deterioran la capacidad de alimentación normal. La mucositis es también uno de los efectos secundarios de la quimioterapia, originada por la toxicidad de la misma sobre el área del tracto digestivo alto. Produce también alteración del gusto y olfato, disminuyendo todo ello la motivación para comer e influyendo negativamente sobre el apetito. Estas alteraciones son más intensas en el tratamiento concomitante con radioterapia, y disminuyen progresivamente al finalizar el mismo.\n\nRadioterapia. La radioterapia (RT) puede estar asociada a complicaciones agudas y crónicas con implicaciones nutricionales muy importantes. La presentación de estos efectos secundarios dependerá de la localización tumoral, y por tanto de la zona y el volumen que deban ser tratados, la dosis total administrada, el tipo de fraccionamiento empleado para su administración y la duración total del tratamiento.\n\nEn general, los efectos secundarios agudos ocurren durante el tratamiento y pueden durar hasta 2 o 3 semanas tras la finalización del mismo. Las complicaciones crónicas continúan o aparecen cuando ya ha finalizado la administración del tratamiento, pudiendo presentarse meses, e incluso años, después de terminada la RT.\n\nInmunoterapia. Se asocia al desarrollo de cansancio, náuseas, vómitos y anorexia, probablemente secundaria a un efecto central. En muchas ocasiones estos fármacos están incluidos en esquemas de quimioterapia para situaciones clínicas muy avanzadas y es prácticamente imposible determinar el peso de cada una de las variables en la situación nutricional del paciente.\n\n### 2.3. Manifestaciones clínicas\n\nLa malnutrición en el paciente neoplásico produce una disminución de masa muscular que conlleva una pérdida de fuerza que tiene importantes consecuencias sobre el estado funcional del individuo, con deterioro de la calidad de vida. Como consecuencia de la progresiva pérdida de peso aparece astenia e inactividad contribuyendo aún más a disminuir la capacidad funcional. Por otra parte, la malnutrición energético-proteica en estos pacientes también afecta a su inmunocompetencia, afectando principalmente a la inmunidad celular y aumentando el riesgo de complicaciones infecciosas, así como los mecanismos de cicatrización y riesgo de complicaciones quirúrgicas, importante fuente de morbilidad en estos pacientes³.\n\nLa inflamación sistémica se asocia con el desarrollo de fatiga, disminución de la actividad física, anorexia y pérdida de peso. Este síndrome inflamatorio puede también alterar o prevenir la recuperación de la masa muscular esquelética, aún si la ingesta energética se normaliza con el soporte nutricional convencional.\n\nTanto la pérdida de peso¹ como la alteración del estado funcional y la inflamación sistémica en pacientes con cáncer se asocian de forma independiente con un pronóstico desfavorable, aumento de la toxicidad de los tratamientos oncológicos dando lugar a interrupción o reducción del esquema de tratamiento y reducción de la calidad de vida. Estos tres factores interactúan entre ellos y resulta en un continuo deterioro de la salud global y el bienestar del paciente.\n\n## 3. Objetivos del tratamiento nutricional\n\nEl objetivo de la intervención nutricional es mantener o mejorar la ingesta energética y mitigar las alteraciones metabólicas, manteniendo la masa de músculo esquelético y la actividad física, disminuyendo el riesgo de reducción o interrupción del esquema de tratamiento oncológico y mejorando la calidad de vida.\n\nDada la alta incidencia de déficits nutricionales y alter\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>NUTRICIÓN EN ONCOLOGÍA<|>EVENT<|>NUTRICIÓN EN ONCOLOGÍA is a field of study focusing on the nutritional needs and interventions for cancer patients, particularly during and after treatment to prevent malnutrition and improve quality of life.)\n##\n(\"entity\"<|>QUIMIOTERAPIA<|>EVENT<|>Quimioterapia is an aggressive cancer treatment that can lead to various side effects affecting the patient's ability to eat and maintain nutrition.)\n##\n(\"entity\"<|>RADIOTERAPIA<|>EVENT<|>Radioterapia is a cancer treatment that can cause acute and chronic complications with significant nutritional implications for patients.)\n##\n(\"entity\"<|>INMUNOTERAPIA<|>EVENT<|>Inmunoterapia is a cancer treatment associated with side effects such as fatigue and nausea, impacting the nutritional status of patients.)\n##\n(\"entity\"<|>MALNUTRICIÓN<|>EVENT<|>Malnutrición in cancer patients leads to muscle mass loss, decreased strength, and negatively affects quality of life and functional status.)\n##\n(\"entity\"<|>CÁNCER<|>EVENT<|>Cáncer is a disease that significantly impacts nutritional status and requires careful management of dietary needs during treatment.)\n##\n(\"entity\"<|>PACIENTE NEOPLÁSICO<|>PERSON<|>Paciente neoplásico refers to individuals diagnosed with cancer who face unique nutritional challenges due to their condition and treatment.)\n##\n(\"relationship\"<|>PACIENTE NEOPLÁSICO<|>MALNUTRICIÓN<|>Malnutrición is a common issue faced by paciente neoplásico due to the effects of cancer and its treatments on nutritional status.<|>8)\n##\n(\"relationship\"<|>PACIENTE NEOPLÁSICO<|>QUIMIOTERAPIA<|>Quimioterapia is a treatment that paciente neoplásico undergo, which can lead to side effects impacting their nutrition.<|>7)\n##\n(\"relationship\"<|>PACIENTE NEOPLÁSICO<|>RADIOTERAPIA<|>Radioterapia is another treatment that paciente neoplásico may receive, causing complications that affect their nutritional needs.<|>7)\n##\n(\"relationship\"<|>PACIENTE NEOPLÁSICO<|>INMUNOTERAPIA<|>Inmunoterapia is a treatment option for paciente neoplásico that can lead to side effects affecting their appetite and nutrition.<|>7)\n##\n(\"relationship\"<|>QUIMIOTERAPIA<|>MALNUTRICIÓN<|>Quimioterapia can lead to malnutrición due to its side effects, such as nausea and vomiting, which hinder normal eating.<|>9)\n##\n(\"relationship\"<|>RADIOTERAPIA<|>MALNUTRICIÓN<|>Radioterapia can cause complications that contribute to malnutrición in cancer patients, affecting their ability to maintain proper nutrition.<|>9)\n##\n(\"relationship\"<|>INMUNOTERAPIA<|>MALNUTRICIÓN<|>Inmunoterapia can lead to malnutrición due to its side effects, impacting the patient's overall nutritional status.<|>8)\n##\n(\"relationship\"<|>CÁNCER<|>MALNUTRICIÓN<|>Cáncer is directly related to malnutrición as the disease and its treatments significantly affect the nutritional needs of patients.<|>10)\n##\n(\"relationship\"<|>CÁNCER<|>QUIMIOTERAPIA<|>Cáncer is treated with quimioterapia, which has various side effects that can impact the patient's nutrition.<|>8)\n##\n(\"relationship\"<|>CÁNCER<|>RADIOTERAPIA<|>Cáncer is also treated with radioterapia, which can lead to nutritional complications for the patient.<|>8)\n##\n(\"relationship\"<|>CÁNCER<|>INMUNOTERAPIA<|>Cáncer may be treated with inmunoterapia, which can affect the patient's appetite and nutritional status.<|>8)\n<|COMPLETE|>"}]}